Why Proteasome Inhibitors Cannot ERADicate Multiple Myeloma

Cancer Cell

Volumn 24, Issue 3, 2013, Pages 275-277

  Orlowski, RobertZ ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BORTEZOMIB; CARFILZOMIB; CYCLOPHOSPHAMIDE; DOXORUBICIN; ENZYME; INOSITOL; INOSITOL REQUIRING ENZYME 1; LENALIDOMIDE; POMALIDOMIDE; PREDNISONE; SOMATOMEDIN RECEPTOR; THALIDOMIDE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; VINCRISTINE SULFATE; X BOX BINDING PROTEIN 1;

B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; CELL ACTIVATION; CLINICAL TRIAL (TOPIC); CROSS RESISTANCE; DRUG SENSITIVITY; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERCALCEMIA; IMMUNOGLOBULIN PRODUCTION; LIVER CANCER; MULTIPLE MYELOMA; OVERALL SURVIVAL; OXIDATIVE STRESS; PRIORITY JOURNAL; RNA INTERFERENCE; SHORT SURVEY; SIDE POPULATION CELL; STEM CELL; STOMACH CANCER; TREATMENT FAILURE; UNFOLDED PROTEIN RESPONSE; UPREGULATION;

EID: 84883614839     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.08.014     Document Type: Short Survey

References (10)

1. Becker N. Recent Results Cancer Res. 2011, 183:25-35.
2. Jakubikova J., Adamia S., Kost-Alimova M., Klippel S., Cervi D., Daley J.F., Cholujova D., Kong S.Y., Leiba M., Blotta S., et al. Blood 2011, 117:4409-4419.
3. Kuhn D.J., Berkova Z., Jones R.J., Woessner R., Bjorklund C.C., Ma W., Davis R.E., Lin P., Wang H., Madden T.L., et al. Blood 2012, 120:3260-3270.
4. Leung-Hagesteijn C., Erdmann N., Cheung G., Keats J.J., Stewart A.K., Reece D., Chung K.C., Tiedemann R.E. Cancer Cell 2013, 24:289-304. this issue.
5. Mahindra A., Laubach J., Raje N., Munshi N., Richardson P.G., Anderson K. Nat Rev Clin Oncol 2012, 9:135-143.
6. Mendelsohn J. J.Clin. Oncol. 2013, 31:1904-1911.
7. Moreau P., Richardson P.G., Cavo M., Orlowski R.Z., San Miguel J.F., Palumbo A., Harousseau J.L. Blood 2012, 120:947-959.
8. Shaughnessy J.D., Qu P., Usmani S., Heuck C.J., Zhang Q., Zhou Y., Tian E., Hanamura I., van Rhee F., Anaissie E., et al. Blood 2011, 118:3512-3524.
9. Smith B.D., Smith G.L., Hurria A., Hortobagyi G.N., Buchholz T.A. J.Clin. Oncol. 2009, 27:2758-2765.
10. Stessman H.A., Baughn L.B., Sarver A., Xia T., Deshpande R., Mansoor A., Walsh S.A., Sunderland J.J., Dolloff N.G., Linden M.A., et al. Mol. Cancer Ther. 2013, 12:1140-1150.